Healthcare Press

Skeletal stem cells in bone development, homeostasis and disease

  • 📰 medical_xpress
  • ⏱ Reading Time:
  • 46 sec. here
  • 7 min. at publisher
  • 📊 Quality Score:
  • News: 39%
  • Publisher: 51%

Medicine Research News News

Medicine Research,Health Research News,Health Research

Skeletal stem cells (SSCs) are essential for bone development, homeostasis, and repair. Recent studies have identified distinct SSC populations in long bones, craniofacial bones, and spine. Techniques like single-cell sequencing have mapped SSC lineage commitment trajectories. SSCs also play roles in bone repair and diseases.

Skeletal stem cells in bone development, homeostasis and disease retrieved 5 June 2024 from https://medicalxpress.com/news/2024-06-skeletal-stem-cells-bone-homeostasis.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Doctors develop minimally invasive procedure to avoid drilling a 'burr hole' in the skull to treat clot on the brainUse this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page.

Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 101. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Recent FDA committee vote could speed multiple myeloma drug approvalA U.S. Food and Drug Administration committee voted unanimously in April to approve a new clinical endpoint, minimal residual disease (MRD), when evaluating proposed drugs to treat multiple myeloma.
Source: medical_xpress - 🏆 101. / 51 Read more »